Skip to main content
. 2021 Sep 8;2021(9):CD013381. doi: 10.1002/14651858.CD013381.pub2

Hesselink 2004.

Methods Study design: RCT
Duration: 104 weeks
Location: Netherlands
Participants Population: asthma or COPD
Baseline characteristics: NR
Inclusion criteria: aged 16–75 years, clinical diagnosis of asthma or COPD or mixed (asthma with persisting airway obstruction), treated by GP, no other respiratory or terminal illness, current asthma or COPD medication use, experienced symptoms in the last 12 months
Exclusion criteria: NR
Interventions Treatment arms
  1. GP‐led education

  2. Usual care from GPs

Outcomes Primary outcomes: degree of dyspnoea (mMRC questionnaire), quality of life in respiratory illness questionnaire
Secondary outcomes: Inhalation technique, self‐efficacy, coping questionnaire
Notes Funding: NR
Other identifier: NR